Klotz L. Testosterone therapy and prostate cancer--safety concerns are well founded. Nat Rev Urol 2015;12:48-54. [Crossref]Klotz L.Testosterone therapy and prostate cancer--safety concerns are well founded [J]. Nat Rev Urol,2015,12( 1 ) :48-54....
Esophageal squamous cell carcinoma (ESCC) is the predominant histologic subtype of esophageal cancer and characterized by high mortality rate and geographic differences in incidence. With the advances in the field of molecular biology, our understanding of the pathogenesis, epidemiology and behavior of ...
"Since the growth of testosterone therapy is relatively recent and prostate cancer is a slow-moving disease, there are at present no data to determine if testosterone could heighten the risk ofprostate cancerin humans," Bosland said. "While human studies are conducted, it would be prudent to ...
Trost, Landon W.Hellstrom, Wayne J.G.John Wiley & Sons, Ltd.Journal of Sexual MedicineLandon W. Trost , Wayne J.G. Hellstrom . (2013) Testosterone Deficiency, Supplementation, and Prostate Cancer: Maintaining a Balanced Perspective. The Journal of Sexual Medicine 10 :10.1111/jsm.2013.10....
Although testosterone is often considered to be a catalyst of prostate cancer, a recent study suggests that the hormone may be able to subdue advanced prostate cancer and break down resistance to testosterone-blocking drugs used to treat the disease. ...
The use of testosterone therapy in men with prostate cancer was previously contraindicated, although recent data challenge this axiom. Over the past 2 decades, there has been a dramatic paradigm shift in beliefs, attitude, and treatment of testosterone deficiency in men with...
医学 禁忌症 前列腺癌 睾酮(贴片) 癌症 重症监护医学 前列腺 妇科 疾病 替代医学 内科学 病理 网址 https://doi.org/10.1016/j.ucl.2022.07.002 AI链接 nih.govdoi.orgDOI 10.1016/j.ucl.2022.07.002 复制 doi 其它 期刊:Urologic Clinics of North America 作者:Álvaro Morales; D. Robert Siemens ...
ProstateZhang PL, Rosen S, Veeramachaneni R, Kao J, DeWolf WC, Bubley G. Association between prostate cancer and serum testosterone levels. Prostate 2002;53:179-82.Zhang PL, Rosen S, Veeramachaneni R, Kao J, DeWolf WC, Bubley G. Association between prostate cancer and serum testos- ...
A treatment paradox has recently come to light in prostate cancer: Blocking testosterone production halts tumor growth in early disease, while elevating the hormone can delay disease progression in patients whose disease has advanced.
摘要: Testosterone therapy for men with prostate cancer is a controversial topic. A recent study retrospectively reviewed a single-centre experience in treating hypogonadal men with prostate cancer with exogenous testosterone therapy and found it to be safe....